Follow
Andre Rogatko
Andre Rogatko
Independent Scientist
No verified email
Title
Cited by
Cited by
Year
Cancer phase I clinical trials: efficient dose escalation with overdose control
J Babb, A Rogatko, S Zacks
Statistics in medicine 17 (10), 1103-1120, 1998
7191998
International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity
AD Auerbach, A Rogatko, TM Schroeder-Kurth
4381989
UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan
LE Carlini, NJ Meropol, J Bever, ML Andria, T Hill, P Gold, A Rogatko, ...
Clinical Cancer Research 11 (3), 1226-1236, 2005
3462005
Prognosis of pregnancy‐associated breast cancer
JA Petrek, R Dukoff, A Rogatko
Cancer 67 (4), 869-872, 1991
3351991
Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women
J Sheinfeld, AJ Schaeffer, C Cordon-Cardo, A Rogatko, WR Fair
New England Journal of Medicine 320 (12), 773-777, 1989
3291989
Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model
JD Cheng, RL Dunbrack Jr, M Valianou, A Rogatko, RK Alpaugh, ...
Cancer research 62 (16), 4767-4772, 2002
3142002
Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification
N Nese, G Martignoni, CD Fletcher, R Gupta, CC Pan, H Kim, JY Ro, ...
The American journal of surgical pathology 35 (2), 161-176, 2011
3102011
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
SJ Cohen, RK Alpaugh, I Palazzo, NJ Meropol, A Rogatko, Z Xu, ...
Pancreas 37 (2), 154-158, 2008
2792008
In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots
MV Yezhelyev, A Al-Hajj, C Morris, AI Marcus, T Liu, M Lewis, C Cohen, ...
ADVANCED MATERIALS-DEERFIELD BEACH THEN WEINHEIM- 19 (20), 3146, 2007
2632007
Translation of innovative designs into phase I trials
A Rogatko, D Schoeneck, W Jonas, M Tighiouart, FR Khuri, A Porter
Journal of Clinical Oncology 25 (31), 4982-4986, 2007
2612007
Changing patterns of bone and brain metastases in patients with colorectal cancer
ML Sundermeyer, NJ Meropol, A Rogatko, H Wang, SJ Cohen
Clinical colorectal cancer 5 (2), 108-113, 2005
2582005
Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma
MS Brady, A Rogatko, LL Dent, MH Shiu
Archives of surgery 126 (3), 359-364, 1991
2401991
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer
SJ Cohen, RK Alpaugh, S Gross, SM O'Hara, DA Smirnov, ...
Clinical colorectal cancer 6 (2), 125-132, 2006
2282006
The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases.
RN Younes, A Rogatko, MF Brennan
Annals of surgery 214 (2), 107, 1991
2211991
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma
SJ Cohen, L Ho, S Ranganathan, JL Abbruzzese, RK Alpaugh, M Beard, ...
Journal of Clinical Oncology 21 (7), 1301-1306, 2003
2172003
Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis
S Josson, M Gururajan, SY Sung, P Hu, C Shao, HE Zhau, C Liu, ...
Oncogene 34 (21), 2690-2699, 2015
2122015
Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis.
DG Coit, A Rogatko, MF Brennan
Annals of surgery 214 (5), 627, 1991
2101991
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7. 1) in patients with …
M von Mehren, P Arlen, J Gulley, A Rogatko, HS Cooper, NJ Meropol, ...
Clinical cancer research 7 (5), 1181-1191, 2001
2082001
Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7. 1 transgenes in patients with recurrent CEA-expressing adenocarcinomas
M von Mehren, P Arlen, KY Tsang, A Rogatko, N Meropol, HS Cooper, ...
Clinical cancer research 6 (6), 2219-2228, 2000
2032000
Prognostic factors in primary retroperitoneal soft-tissue sarcomas
RG Bevilacqua, A Rogatko, SI Hajdu, MF Brennan
Archives of surgery 126 (3), 328-334, 1991
2011991
The system can't perform the operation now. Try again later.
Articles 1–20